← FDA Drug Approvals (Drugs@FDA)
HY-PAM "25"
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA · Approved 1985-03-04
Drug application
- FDA Application #
ANDA088713- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HY-PAM "25"
- Generic name
- Hydroxyzine Pamoate
- Active ingredients
- HYDROXYZINE PAMOATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA
- First approval
- 1985-03-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown